Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04696731 |
|---|---|
| Brief Title: | Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma (TRAVERSE) |
| First Submitted : | January 4, 2021 |
| First Submitted that Met QC Criteria : | January 4, 2021 |
| First Posted : | January 6, 2021 |
| Last Update Submitted that Met QC Criteria : | March 25, 2022 |
| Last Update Posted : | March 29, 2022 |